Lee, Brian T <br/><br/>
Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated Rejection.  [electronic resource] 

 -  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society  12 2019 
 - 1845-1848 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1527-6473 
<br/><br/><label>Standard No.: </label>10.1002/lt.25622  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Allografts--drug effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Carcinoma, Squamous Cell--diagnosis<br/>End Stage Liver Disease--surgery<br/>Graft Rejection--blood<br/>Humans<br/>Isoantibodies--blood<br/>Liver--drug effects<br/>Liver Transplantation--adverse effects<br/>Male<br/>Nivolumab--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Skin Neoplasms--diagnosis<br/>T-Lymphocytes--drug effects